Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07046351 · ClinicalTrials.gov registry record · NA

weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents

A NA study of Sugary Beverages, sponsored by University of Virginia.

Recruiting
Registry status
NA
Development phase
744
Enrollment target
1
Study location

NCT07046351 is a NA study of Sugary Beverages that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 744 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07046351, a NA study of Sugary Beverages, is actively recruiting participants, sponsored by University of Virginia.

RECRUITING
Registry status
NA
Development phase
744 participants
Enrollment target
1
Study location

Study Summary

This study will include 12 rural Head Start programs, randomly assigned to one of two groups: weSIPsmarter vs. control. The main goal is to find out if weSIPsmarter helps reduce sugary drink consumption in preschool-aged children and their parents.

Conditions Studied

Interventions

  • BEHAVIORAL weSIPsmarter
  • BEHAVIORAL weLearn2Read

Study Locations (1)

Virginia

  • University of Virginia - Christiansburg

Trial Details

FieldValue
Enrollment Target 744 participants
Start Date 2025-08-06
Est. Completion 2029-02-01
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT07046351

The ClinicalTrials.gov registry entry for NCT07046351 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 744 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sugary Beverages appearing as the primary indexed condition, and to 2 interventions - of which weSIPsmarter is the first listed.

NCT07046351 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT07046351 about?

NCT07046351 is a clinical study titled "weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents". This study will include 12 rural Head Start programs, randomly assigned to one of two groups: weSIPsmarter vs. control. The main goal is to find out if weSIPsmarter helps reduce sugary drink consumption in preschool-aged children and their parents.

What is the current status of trial NCT07046351?

This trial is currently recruiting. It is a NA study. The enrollment target is 744 participants. The study started on 2025-08-06. Estimated completion is 2029-02-01.

What conditions does trial NCT07046351 study?

This clinical trial studies the following conditions: Sugary Beverages.

What interventions are being tested in trial NCT07046351?

The interventions under investigation include: weSIPsmarter (BEHAVIORAL), weLearn2Read (BEHAVIORAL).

Who is sponsoring clinical trial NCT07046351?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07046351 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sugary Beverages

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.